References

  1. World Health Organization. Hepatitis B: fact sheet no 204. Updated July 2016. Accessed August 25th 2016.

  2. Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Centers for Disease Control and Prevention. 2009; 1–206. Google Scholar

  3. World Health Organization. Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework. World Health Organization Geneva. 2016. Google Scholar

  4. United Nations Programme on HIV/AIDS. Global AIDS update 2016. Updated July 2016. Accessed August 25th 2016.

  5. Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases, a systematic review and meta-analysis. Int J Infect Dis. 2010; 14 (12): e1024–31. PubMed | Google Scholar

  6. Gatanaga H, Yasuoka A, Kikuchi Y, Tachikawa N, Oka S. Influence of prior HIV-1 infection on the development of chronic hepatitis B infection. Eur J Clin Microbiol Infect Dis. 2000; 19(3): 237-9. PubMed | Google Scholar

  7. Brito M, Alhyraba M. Hepatitis B in patients coinfected with HIV. Hosp Physician. 2008; 20:17–23. Google Scholar

  8. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007; 7(6):402 – 9. PubMed | Google Scholar

  9. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Muñoz A et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002; 360(9349): 1921-6. PubMed | Google Scholar

  10. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005; 19(6): 593-601. PubMed | Google Scholar

  11. Weber R, Sabin CA, Frils-Møller N, Reiss P, El-Sadr WM, Kirk O et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006; 166(15):1632-41. PubMed | Google Scholar

  12. Hawkins C, Christian B, Ye J, Nagu T, Aris E, Chalamilla G et al. Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania. AIDS. 2013; 27(6):919 – 927. PubMed | Google Scholar

  13. World Health Organization. Combating Hepatitis B and C to reach elimination by 2030: advocacy brief. Geneva Switzerland, WHO. 2016. Google Scholar

  14. Fix OK, Locarnini SA, Development M, Peters MG. Virology and Clinical Management of Hepatitis B and HIV Coinfection.Physician Research Network. 2007; 11: 20–27.

  15. Nagu TJ, Bakari M, Matee M. Hapatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health. 2008; 8: 416. Google Scholar

  16. MOHSW. Expanded Programme on immunization 2006-2010, Tanzania: Comprehensive Multiyear Plan. Dar es Salaam, Tanzania, Government Press. 2007; 2nd edition. Google Scholar

  17. 1. The United Republic of TanzaniaPresident's Office Regional Administration and Local Government. Moshi Municipality Council: Districts of Kilimanjaro including Moshi Municipal Council . 2013. Accessed September 2016.

  18. Attia K, Eholié S, Messou E, Danel C, Polneau S, Chenal H et al. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. World J Hepatol. 2012; 4(7): 218-223. PubMed | Google Scholar

  19. Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. Afr Health Sci. 2012; 12(3): 312 – 317. PubMed | Google Scholar

  20. Boyles TH, Cohen K. The prevalence of hepatitis B infection in a rural South African HIV clinic. S Afr Med J. 2011; 101(7): 470-471. PubMed | Google Scholar

  21. Matthews PC, Beloukas A, Malik A, Carlson JM, Jooste P, Ogwu A et al. Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana. PLoS ONE. 2015; 10(7): e0134037. PubMed | Google Scholar

  22. Baseke J, Musenero M, Mayanja-Kizza H. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda. Afr Health Sci. 2015; 15(2): 322-327. PubMed | Google Scholar

  23. Matee MI, Magesa E, Lyamuya EF. Seroprevalence of human immunodeficiency, hepatitis B and C viruses and Sphiylis infection among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health. 2006; 6: 21.

  24. Rashid S, Kilewo C, Abood S. Seroprevalence of hepatitis B virus infection among antenatal clinic attendees at tertiary hospiral in Dar es Salaam, Tanzania. Tanzan J of Health Res. 2014; 16(1): 9-15. PubMed | Google Scholar

  25. Msuya SE, Mbizvo EM, Hussain A, Sam NE, Stray-Pedersen B. Seroprevalence of Hepatitis B and C viruses among women of childbearing age in Moshi urbun,Tanzania. East Afr Med J. 2006; 83(2):92-94. PubMed | Google Scholar

  26. Benhamou Y, Bochet M, Thibault V, Di Martino V, Caumes E, Bricaire F et al. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology. 1999; 30(5):1302-6. PubMed | Google Scholar

  27. Gu L, Han Y, Li Y, Zhu T, Song X, Huang Y et al. Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China. PLoS ONE. 2015; 10(8):e0134539. PubMed | Google Scholar

  28. Mauka WI, Mahande MJ, Msuya SE, Philemon RN. Factors associated with repeated blood donation at the northern zone blood transfusion centre in Tanzania. Journal of Blood Transfusion. 2015; 2015:717653. Google Scholar